Eisai Co. Ltd.
Company Snapshot
Founded: 1941
Entity Type: Public
Employees: 11067
Region: Japan
Revenue: $5,139.6 Millions
Revenue Year: 2023
Segment: Pharmaceutical business
Headquarter: Tokyo, Japan
Corporate Address: 4-6-10 Koishikawa, Bunkyo-ku, Tokyo 112-8088, Japan Tel. +81-3-3817-3700 www.eisai.com
Company Overview
Eisai Co., Ltd., previously Sakuragaoka Research Laboratory. It was renamed Eisai in 1995. The pharmaceutical company research, develops, manufactures, and markets pharmaceuticals, chemicals, food additives, and machinery and equipment for pharmaceutical production. Research areas include neurology, oncology, cardiology, gastrointestinal, musculoskeletal diseases and contrast solutions. It predominately focuses on the therapeutic areas of treatment.
Financial Highlights (FY 2023)
Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***
This information is available for BCC Research members only.
Company's Business Segments
- Pharmaceutical business : This segment includes Lenvima, Dayvigo, Leqembi, Halaven, Fycompa.
- Other business : Other business mainly includes the License Revenue, Pharmaceutical Ingredient Business of the company.
Applications/End User Industries
- Clinical Research
- Clinical Trials
- Oncology
- Drug Creation Research
- Drug Development
- Clinical Study Reports
- Statistical Analysis Plan
- Dementia
- Tropical Diseases
BCC Research Beacon 